FDA
approval
· 2026-04-01
FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (Somerset Therapeutics, LLC)
Summary
FDA approved a supplemental application for PROCHLORPERAZINE EDISYLATE (ANDA212257) filed by Somerset Therapeutics, LLC. This approval relates to the generic pr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for PROCHLORPERAZINE EDISYLATE (PROCHLORPERAZINE EDISYLATE)